Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
(UroToday.com) During the Stones Medical Management poster session at the World Congress of Endourology and Uro-Technology, Qiuchen Li, a second-year medical student at Case Western Reserve University School of Medicine, presented a study investigating the impact of GLP-1 receptor agonists (GLP-1As) on nephrolithiasis in patients with obesity
It occurs when the glucose level in your blood falls below normal
Irritable bowel syndrome affects 1015% of the global population, causing chronic abdominal pain, bloating, and unpredictable bowel habits that significantly impact quality of life
Factors such as lifestyle compatibility and comfort with structured products matter
This story mentions GLP-1 drugs, which are FDA-approved for weight management in adults diagnosed with obesity or with overweight and at least one weight-related health condition
When weight reduction occurs without a plan to protect muscle, that natural decline can become more pronounced
US$ 29.30
US$ 23.83
US$ 27.87
